CD4+ T Cell Reconstitution Biomarkers: Predicting Immune Recovery in Treatment-Naïve HIV Patients

Mpora Kakwanzi Evelyn

Department of Pharmacognosy Kampala International University Uganda

Email: evelyne.mpora@studwc.kiu.ac.ug

                                                                                          ABSTRACT
Antiretroviral therapy (ART) suppressed HIV replication and permitted partial restoration of CD4+ T cell immunity, yet the magnitude and tempo of immune recovery vary widely among treatment-naïve patients. Incomplete CD4 reconstitution sustained vulnerability to opportunistic infections, immune activation, and nonAIDS comorbidities despite viral suppression. This review evaluated candidate biomarkers that predict CD4+ T cell reconstitution after ART initiation in treatment-naïve HIV patients and appraised their translational potential for risk stratification and clinical decision-making. A narrative, evidence-informed synthesis was developed from peerreviewed cohort studies, mechanistic biomarker investigations, and clinical literature addressing immune activation, inflammation, thymic function, gut barrier integrity, and lymphoid tissue remodeling in ART-mediated recovery. Baseline CD4 count and viral load explained only part of recovery heterogeneity. Biomarkers reflecting immune activation and inflammation (for example IL 6, CRP, D dimer, soluble CD14), gut barrier injury and microbial translocation (LPS related measures, intestinal fatty acid binding protein), thymic output and homeostatic signaling (T cell receptor excision circles, IL 7 axis), and T cell senescence or exhaustion phenotypes (CD57, PD 1 related markers) repeatedly associated with slower CD4 gain and persistent immune dysfunction. Composite models combining clinical variables with biomarker panels generally improved prediction compared with routine measures alone, though standardization and external validation remain limiting. Predictive biomarkers for CD4 reconstitution were biologically plausible and increasingly supported, but their routine use required pragmatic assays, validated thresholds, and equity-focused implementation.

Keywords: HIV, CD4+ T cell reconstitution, Immune activation, Thymic output, Microbial translocation.

CITE AS: Mpora Kakwanzi Evelyn (2026). CD4+ T Cell Reconstitution Biomarkers: Predicting Immune Recovery in Treatment-Naïve HIV Patients. IDOSR JOURNAL OF APPLIED SCIENCES 11(2):94-99.
https://doi.org/10.59298/IDOSRJAS/2026/1129499